PL2273975T3 - Roztwory farmaceutyczne, sposoby wytwarzania i zastosowania terapeutyczne - Google Patents

Roztwory farmaceutyczne, sposoby wytwarzania i zastosowania terapeutyczne

Info

Publication number
PL2273975T3
PL2273975T3 PL09716304T PL09716304T PL2273975T3 PL 2273975 T3 PL2273975 T3 PL 2273975T3 PL 09716304 T PL09716304 T PL 09716304T PL 09716304 T PL09716304 T PL 09716304T PL 2273975 T3 PL2273975 T3 PL 2273975T3
Authority
PL
Poland
Prior art keywords
preparation
therapeutic uses
pharmaceutical solutions
pharmaceutical
solutions
Prior art date
Application number
PL09716304T
Other languages
English (en)
Inventor
Eric Schenkel
Claire Poulain
Bertrand Dodelet
Domenico Fanara
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39643757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2273975(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Publication of PL2273975T3 publication Critical patent/PL2273975T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
PL09716304T 2008-03-03 2009-03-02 Roztwory farmaceutyczne, sposoby wytwarzania i zastosowania terapeutyczne PL2273975T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08003915 2008-03-03
EP09716304.2A EP2273975B8 (en) 2008-03-03 2009-03-02 Pharmaceutical solutions, process of preparation and therapeutic uses
PCT/EP2009/052454 WO2009109547A1 (en) 2008-03-03 2009-03-02 Pharmaceutical solutions, process of preparation and therapeutic uses

Publications (1)

Publication Number Publication Date
PL2273975T3 true PL2273975T3 (pl) 2014-09-30

Family

ID=39643757

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09716304T PL2273975T3 (pl) 2008-03-03 2009-03-02 Roztwory farmaceutyczne, sposoby wytwarzania i zastosowania terapeutyczne

Country Status (21)

Country Link
US (1) US20110021786A1 (pl)
EP (1) EP2273975B8 (pl)
JP (6) JP2011513360A (pl)
KR (1) KR101353425B1 (pl)
CN (1) CN101945647B (pl)
AU (1) AU2009221177B2 (pl)
BR (1) BRPI0908421C1 (pl)
CA (1) CA2715685C (pl)
CY (1) CY1115254T1 (pl)
DK (1) DK2273975T3 (pl)
EA (1) EA018736B1 (pl)
ES (1) ES2474945T3 (pl)
HK (1) HK1148202A1 (pl)
HR (1) HRP20140634T1 (pl)
IL (1) IL207558A (pl)
MX (1) MX2010009222A (pl)
PL (1) PL2273975T3 (pl)
PT (1) PT2273975E (pl)
RS (1) RS53418B (pl)
SI (1) SI2273975T1 (pl)
WO (1) WO2009109547A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009109547A1 (en) * 2008-03-03 2009-09-11 Ucb Pharma, S.A. Pharmaceutical solutions, process of preparation and therapeutic uses
DK3260118T3 (da) * 2008-10-16 2021-04-19 Univ Johns Hopkins Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
DK3106463T6 (da) 2008-10-22 2020-02-24 Array Biopharma Inc Pyrazolo[1,5-]pyrimidinforbindelse som trk-kinasehæmmer
ES2602606T3 (es) * 2008-11-18 2017-02-21 Ucb Biopharma Sprl Formulaciones de liberación prolongada que comprenden un derivado de 2-oxo-1-pirrolidina
RS54692B1 (en) 2011-12-16 2016-08-31 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. PHARMACEUTICAL COMPOSITION COVERING (S) -2- (OXOPYROLIDIN-1-IL) BUTANAMIDE
CN102525900A (zh) * 2012-01-19 2012-07-04 南京恒道医药科技有限公司 左乙拉西坦注射液及其制备方法
US20130280346A1 (en) * 2012-04-19 2013-10-24 C. R. Bard, Inc. Infusates with Enhanced pH Stability Under Ethylene Oxide Sterilization
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
CN103550143B (zh) * 2013-10-19 2019-05-14 浙江华海药业股份有限公司 一种左乙拉西坦注射液的制备方法
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
US10973783B2 (en) 2015-12-30 2021-04-13 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of seizure-related disorders
PE20181888A1 (es) * 2016-04-04 2018-12-11 Loxo Oncology Inc Formulaciones liquidas de (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida
US10045991B2 (en) 2016-04-04 2018-08-14 Loxo Oncology, Inc. Methods of treating pediatric cancers
EP3800189B1 (en) 2016-05-18 2023-06-28 Loxo Oncology, Inc. Preparation of (s)-n-(5-((r)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
CN106491523A (zh) * 2016-09-24 2017-03-15 北京万全德众医药生物技术有限公司 一种布瓦西坦口服溶液及其制备方法
EP3826610A4 (en) * 2018-07-24 2022-05-04 Zenvision Pharma LLP SYSTEM FOR NASAL DRUG DELIVERY OF BRIVARACETAM OR A SALT THEREOF
US20210393588A1 (en) * 2018-11-02 2021-12-23 Zenvision Pharma Llp Ready to use intravenous infusion of brivaracetam or salt thereof
US20220187503A1 (en) 2019-03-28 2022-06-16 Toyobo Co., Ltd. Anti-reflection circular polariser and image display device using same
CN113908120A (zh) * 2021-09-30 2022-01-11 北京诺康达医药科技股份有限公司 布立西坦药物溶液及其制备方法
CN114213306A (zh) * 2021-12-28 2022-03-22 海南鑫开源医药科技有限公司 一种布瓦西坦酸杂质的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US7612215B2 (en) * 2004-06-11 2009-11-03 Ucb Pharma, S.A. Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation
EP1731149A1 (en) * 2005-06-08 2006-12-13 Ucb S.A. Use of 2-oxo-1-pyrrolidone derivatives for the treatment of diseases characterized by progressive myoclonic epilepsy
WO2009109547A1 (en) * 2008-03-03 2009-09-11 Ucb Pharma, S.A. Pharmaceutical solutions, process of preparation and therapeutic uses
KR101286540B1 (ko) * 2008-04-16 2013-07-17 엘지디스플레이 주식회사 액정표시장치

Also Published As

Publication number Publication date
IL207558A (en) 2015-02-26
DK2273975T3 (da) 2014-06-30
AU2009221177A1 (en) 2009-09-11
IL207558A0 (en) 2010-12-30
JP2022169734A (ja) 2022-11-09
HK1148202A1 (en) 2011-09-02
SI2273975T1 (sl) 2014-09-30
WO2009109547A1 (en) 2009-09-11
CN101945647B (zh) 2013-01-09
JP2015145382A (ja) 2015-08-13
ES2474945T3 (es) 2014-07-10
EP2273975A1 (en) 2011-01-19
RS53418B (en) 2014-12-31
PT2273975E (pt) 2014-07-17
CA2715685C (en) 2015-04-28
EP2273975B1 (en) 2014-04-09
BRPI0908421A2 (pt) 2015-08-04
CN101945647A (zh) 2011-01-12
BRPI0908421B8 (pt) 2020-08-18
KR101353425B1 (ko) 2014-02-18
CA2715685A1 (en) 2009-09-11
JP2017114890A (ja) 2017-06-29
JP2019089837A (ja) 2019-06-13
KR20100126466A (ko) 2010-12-01
AU2009221177B2 (en) 2013-05-30
BRPI0908421C1 (pt) 2021-05-25
US20110021786A1 (en) 2011-01-27
MX2010009222A (es) 2010-09-28
EA018736B1 (ru) 2013-10-30
CY1115254T1 (el) 2017-01-04
JP2020128384A (ja) 2020-08-27
BRPI0908421B1 (pt) 2020-08-04
JP2011513360A (ja) 2011-04-28
HRP20140634T1 (hr) 2014-11-21
EP2273975B8 (en) 2014-12-17
EA201001402A1 (ru) 2011-06-30

Similar Documents

Publication Publication Date Title
SI2273975T1 (sl) Farmacevtske raztopine, postopek priprave in terapevtska uporaba
HUS1600057I1 (hu) Kezelési eljárások ammónia-megkötõ hatóanyag alkalmazásával
HK1161878A1 (en) Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
HK1159108A1 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
EP2265591A4 (en) NITROGEN-CONTAINING COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE IN MEDICAMENT MANUFACTURE
IL208336A (en) Pyridazinone derivatives, drugs containing them and their uses and process for preparation
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
IL207799A0 (en) Azetidine-derived compounds, preparation method therefor and therapeutic use of same
HRP20181877T1 (hr) Postupci za liječenje lijekovima koji uklanjaju amonijak
ZA201103516B (en) Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
IL213177A0 (en) Crystal forms, methods of preparation, pharmaceutical compositions and uses of nicousamide
HK1158632A1 (en) Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same 2--1--2-
IL211062A0 (en) Pharmaceutical uses of lanosta-8,24-dien-3-ols
IL219872A (en) Quinazoline derivatives, their uses, their preparation, and their medications
GB2488494B (en) Solution, use and method of preparation thereof
PL2106401T3 (pl) Pochodne pirolopirydyno-2-karboksyamidów, ich wytwarzanie i ich zastosowanie w lecznictwie
HK1164861A1 (en) Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
IL216746A (en) History of imidazole, the process of preparing them, and their use in the preparation of drugs for treatment
SI2421864T1 (sl) 1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba
SI2330892T1 (sl) Postopki zdravljenja z uporabo zdravil, ki odstranjujejo amoniak
HUP0900305A2 (en) Peptide derivatives, process for their preparation and their therapeutical use
PL388789A1 (pl) Kompozycja farmaceutyczna zawierajaca rosuwastatynę, sposób jej wytwarzania oraz postacie leku zawierające tę kompozycję